Evidence map›Paper›PMID 35907865›Full record

ArticleHealth and quality of life outcomes2022

ADaPTS "(AD)olescents (P)ath through (T)ransplant (S)ickle cell disease".

Aisha A K Bruce, Gregory M T Guilcher, Sunil Desai, Tony H Truong, Michael Leaker, Dominic A Alaazi, Sasia J V Pedersen, Bukola Salami

Open access · goldAbstract read
In one paragraph

Article in Health and quality of life outcomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Aisha A K BruceDivision of Pediatric Hematology and Oncology, 3-467 Edmonton Clinic Health Academy (ECHA), Department of Pediatrics, Faculty of Medicine, University of Alberta, 11405 - 87 Avenue, Edmonton, AB, T6G 1C9, Canada. aisha1@ualberta.ca.
Gregory M T GuilcherSection of Pediatric Oncology/Cellular Therapy, Alberta Children's Hospital, Departments of Oncology and Pediatrics, Cumming School of Medicine, Calgary, AB, Canada.
Sunil DesaiDivision of Pediatric Hematology and Oncology, 3-467 Edmonton Clinic Health Academy (ECHA), Department of Pediatrics, Faculty of Medicine, University of Alberta, 11405 - 87 Avenue, Edmonton, AB, T6G 1C9, Canada.
Tony H TruongSection of Pediatric Oncology/Cellular Therapy, Alberta Children's Hospital, Departments of Oncology and Pediatrics, Cumming School of Medicine, Calgary, AB, Canada.
Michael LeakerSection of Pediatric Oncology/Cellular Therapy, Alberta Children's Hospital, Departments of Oncology and Pediatrics, Cumming School of Medicine, Calgary, AB, Canada.
Dominic A AlaaziFaculty of Nursing, University of Alberta, Edmonton, AB, Canada.
Sasia J V PedersenDivision of Pediatric Hematology and Oncology, 3-467 Edmonton Clinic Health Academy (ECHA), Department of Pediatrics, Faculty of Medicine, University of Alberta, 11405 - 87 Avenue, Edmonton, AB, T6G 1C9, Canada.
Bukola SalamiFaculty of Nursing, University of Alberta, Edmonton, AB, Canada.
Alberta Children's Hospital · CAUniversity of Alberta · CAUniversity of Alberta Hospital · CAAlberta Health Services · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSickle cell disease is an inherited chronic hematological disorder with an average lifespan of fifty years. The human cost of sickle cell disease includes missed school days, occupational opportunities, social isolation, stigmatization, and psychological sequelae. Hematopoietic cell transplantation (HCT) is the only curative therapy available but comes with potential morbidity and mortality. Our study explores how quality of life (QoL) is affected from the perspective of an adolescent who has undergone a nonmyeloablative matched sibling donor HCT.

methodsWe employed multiple case study methodology with purposeful sampling by selecting information-rich cases. DATA SOURCES: 1) QoL inventories 2) patient interviews 3) parent interview 4) vital support interview 5) medical record analysis. DATA ANALYSIS: Intra-case analysis by assembling evidence within a single case and then analyzing the differences within cases to create a rich case description. Next, a time series analysis was completed to track changes in patients' QoL. We used multiple sources of data to compose a timeline and changes across time. Then, we employed pattern matching as an analytical technique allowing for examination of patterns across cases. Finally, we used cross case synthesis to review results of each case.

resultsQuality of life was reported across the physical, social and psychological domains for 5 participants. All had sickle cell HgSS genotype, 80% were male and 80% were born outside of Canada. Physical domain: pre-transplant, 100% of patients experienced pain, and the majority suffered from fatigue, insomnia, and fevers resulting in hospitalizations. Afterwards, participants reported improved physical wellbeing. Social domain: pre-transplant, QoL was poor characterized by stigma, social isolation, and parental absenteeism. Post-HSCT adolescents gained social acceptance in areas that had stigmatized and excluded them. They were able to participate freely in activities with peers and their social life vastly improved. Psychological pre-transplant life experiences were overshadowed by psychological stress. The majority commented that their future was bleak and may lead to premature death. Afterwards adolescents described a crisis free life with positive psychological outcomes.

conclusionsAdolescents with sickle cell disease who undertook HCT demonstrated improved QoL one year post transplant with regard to physical, social and psychological well-being.

Indexed as

Anemia, Sickle CellHematopoietic Stem Cell TransplantationAdolescentFemaleHumansMaleQuality of LifeStress, Psychological

Identifiers

PMID35907865
PMCPMC9338650
OpenAlexW4288748577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.